Related Experiment Video
Updated: May 22, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study
F Dentali1, D Poli, U Scoditti
1Department of Clinical Medicine, University of Insubria, Varese, Italy. fdentali@libero.it
Insights
Long-term outcomes for cerebral vein thrombosis (CVT) are generally good, with low mortality and recurrence rates. A history of venous thromboembolism (VTE) is a key predictor of future CVT events.
Area of Science:
- Neurology
- Vascular Medicine
- Thrombosis Research
Background:
- Limited data exists on the long-term clinical outcomes following cerebral vein thrombosis (CVT).
- Understanding long-term prognosis is crucial for patient management and risk stratification.
Purpose of the Study:
- To evaluate long-term mortality, disability, and recurrence rates of venous thromboembolism (VTE) in patients with a first-time CVT episode.
- To identify predictors of recurrent VTE events in this cohort.
Main Methods:
- International, retrospective cohort study.
- Inclusion of 706 patients with a first CVT episode.
- Follow-up for a total of 3171 patient-years, with a median follow-up of 40 months.
Main Results:
- Overall mortality was low at 2.8% (20 deaths).
- Complete recovery (modified Rankin Score 0-1) was achieved by 89.1% of patients.
- CVT recurrence occurred in 4.4% of patients, with an overall VTE recurrence incidence of 23.6 events per 1000 patient-years.
Conclusions:
- Long-term mortality and recurrent VTE risks are low for survivors of the acute CVT phase.
- A prior history of VTE is an independent predictor of recurrent events.
Background:
Little information is available on the long-term clinical outcome of cerebral vein thrombosis (CVT).
Objectives And Methods:
In an international, retrospective cohort study, we assessed the long-term rates of mortality, residual disability and recurrent venous thromboembolism (VTE) in a cohort of patients with a first CVT episode.
Results:
Seven hundred and six patients (73.7% females) with CVT were included. Patients were followed for a total of 3171 patient-years. Median follow-up was 40 months (range 6, 297 months). At the end of follow-up, 20 patients had died (2.8%). The outcome was generally good: 89.1% of patients had a complete recovery (modified Rankin Score [mRS] 0-1) and 3.8% had a partial recovery and were independent (mRS 2). Eighty-four per cent of patients were treated with oral anticoagulants and the mean treatment duration was 12 months. CVT recurred in 31 patients (4.4%), and 46 patients (6.5%) had a VTE in a different site, for an overall incidence of recurrence of 23.6 events per 1000 patient-years (95% confidence Interval [CI] 17.8, 28.7) and of 35.1 events/1000 patient-years (95% CI, 27.7, 44.4) after anticoagulant therapy withdrawal. A previous VTE was the only significant predictor of recurrence at multivariate analysis (hazard ratio [HR] 2.70; 95% CI 1.25, 5.83).
Conclusions:
The long-term risk of mortality and recurrent VTE appears to be low in patients who survived the acute phase of CVT. A previous VTE history independently predicts recurrent events.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis IV: Nursing Management
Hemorrhagic Stroke ll: Pathophysiology
